vancomycin has been researched along with creatine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Courtois, P; de Lemos, E; Fauconneau, B; Pariat, C; Piriou, A | 1 |
Birt, JK; Chandler, MH | 1 |
Horowitz, GL; Traverse, W; Yeo, KT | 1 |
Borderon, JC; Chamboux, C; Laugier, J; Mathieu, A; Saliba, E | 1 |
Andrés, MS; Cruz, AM; López-Sanromán, J; Román, FS; Rubio-Martínez, LM; Santos, M | 1 |
Bergamasco, S; Donadio, C; Malacarne, P | 1 |
Arns, A; Glasmacher, A; Hahn-Ast, C; Marklein, G; Mühling, A; Orlopp, K; Von Lilienfeld-Toal, M | 1 |
Hashida, T; Inui, K; Katsura, T; Masuda, S; Omote, S; Yano, I; Yano, Y | 1 |
Aksoy, NH; Baykal, A; Celik-Ozenci, C; Dalaklioglu, S; Gungor, NE; Tasatargil, A; Tekcan, M | 1 |
Hisaka, A; Suzuki, H; Terakawa, H; Yamamoto, T | 1 |
Bauer, MP; Dale, AP; Fawley, WN; Gerding, DN; Gorbach, SL; Hensgens, MP; Kuijper, EJ; Miller, MA; Wilcox, MH | 1 |
Cassat, JE; Di Pentima, MC; Gillon, JE | 1 |
Collins, SH; D'Agostino, RB; Gorbach, S; Kean, Y; Pencina, KM | 1 |
1 trial(s) available for vancomycin and creatine
Article | Year |
---|---|
Risk estimation for recurrent Clostridium difficile infection based on clinical factors.
Topics: Adult; Age Factors; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Creatine; Female; Fidaxomicin; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Recurrence; Risk Factors; Vancomycin; Young Adult | 2014 |
13 other study(ies) available for vancomycin and creatine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Circadian variations in the nephrotoxicity of the vancomycin-gentamicin combination in rats].
Topics: Acetylglucosaminidase; Aminopeptidases; Animals; CD13 Antigens; Chemical and Drug Induced Liver Injury; Circadian Rhythm; Creatine; Drug Therapy, Combination; Gentamicins; Liver Diseases; Male; Rats; Rats, Inbred Strains; Vancomycin | 1991 |
Using clinical data to determine vancomycin dosing parameters.
Topics: Adult; Aged; Creatine; Half-Life; Humans; Middle Aged; Vancomycin | 1990 |
Clinical performance of the EMIT vancomycin assay.
Topics: Autoanalysis; Creatine; Dose-Response Relationship, Drug; Humans; Immunoenzyme Techniques; Quality Control; Reagent Kits, Diagnostic; Vancomycin | 1989 |
[Continuous infusion of vancomycin during the neonatal period].
Topics: Creatine; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Staphylococcal Infections; Time Factors; Vancomycin | 1994 |
Evaluation of safety and pharmacokinetics of vancomycin after intravenous regional limb perfusion in horses.
Topics: Analysis of Variance; Animals; Creatine; Forelimb; Gait; Horses; Infusions, Intravenous; Synovial Fluid; Time Factors; Urea; Vancomycin | 2005 |
Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Creatine; Critical Illness; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Vancomycin | 2006 |
An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Topics: Anti-Bacterial Agents; Creatine; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Infections; Kidney; Male; Middle Aged; Multivariate Analysis; Neutropenia; Teicoplanin; Vancomycin | 2008 |
A retrospective analysis of vancomycin pharmacokinetics in Japanese cancer and non-cancer patients based on routine trough monitoring data.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Aspartate Aminotransferases; Bayes Theorem; Blood Urea Nitrogen; Creatine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Retrospective Studies; Serum Albumin; Vancomycin; Young Adult | 2009 |
Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Biomarkers; Blood Urea Nitrogen; Body Weight; Creatine; Isoquinolines; Kidney; Kidney Diseases; Male; Organ Size; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolines; Rats; Rats, Wistar; Vancomycin | 2010 |
Bayesian estimation of pharmacokinetic parameters of vancomycin in patients with decreasing renal function.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Creatine; Drug Dosage Calculations; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Models, Biological; Vancomycin | 2012 |
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Creatine; Fever; Fidaxomicin; Humans; Leukocyte Count; Leukocytosis; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; ROC Curve; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin | 2012 |
Validation of two vancomycin nomograms in patients 10 years of age and older.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Weight; Child; Creatine; Female; Guidelines as Topic; Humans; Male; Reproducibility of Results; Vancomycin; Young Adult | 2014 |